Embecta Corp. has grown revenue −2.9% a year over three years and −0.09% a year over five, with earnings per share compounding at 20%. Revenue growth, 3-year annual rate: −2.9% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: −0.09%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +20%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 6, FY2020 to FY2025, as filed.

EMBCEmbecta Corp.

Healthcare

$3.35-66% 1Y

$3.35

$2.8952 weeks$14.20

Is it growing?

Mixed

Neither accelerating nor breaking down: operating margin widening (+2.7 points), but revenue shrinking (−8% year on year).

1 good, 1 to watch, 1 neutral

Revenue trend−8% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend+4% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+2.7 points operating

Trailing-twelve-month operating margin, 21.7% now against 19.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is EMBC growing?

Embecta Corp. has grown revenue −2.9% a year over three years and −0.09% a year over five, with earnings per share compounding at 20%.

−2.9%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −0.09%
Revenue growth, 5-year rate · −2.9% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +20%
Earnings per share, 3-year rate · revenue −2.9% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed